Shanghai HeartCare Medical Technology Corporation Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 183.03 million compared to CNY 90.09 million a year ago. Net loss was CNY 200.38 million compared to CNY 194.23 million a year ago.

Basic loss per share from continuing operations was CNY 5.24 compared to CNY 5.82 a year ago.